Approval · Notice of Compliance 14080 · 2013
LYSTEDA: Notice of Compliance 14080
Issued February 13, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14080
- Date
- February 13, 2013
- Company
- Ferring Inc.North York, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Antifibrinolytic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| LYSTEDA | 02401959 | Cancelled Pre Market |
Medicinal ingredients
- TRANEXAMIC ACID 650 MG per TAB